Learn how pH-sensitive dye detection supports reliable ADC internalization assays and insight into cellular uptake mechanisms ...

The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple ...

Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or COVID vaccine injuryParticipants to include people ...

A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...

Samsung Biologics expands Korea CRDMO lead with MCB and vector services Samsung Biologics widens CRDMO edge with new MCB and ...

In 2020, the world watched anxiously as scientists scrambled to develop defences against COVID-19. Faced with a new, deadly infectious disease, immunologists worked day and night to develop vaccines ...

The FDA has granted orphan drug designation (ODD) to LP-284, a next-generation acylfulvene small molecule, for the treatment ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

Sixth overall for Lantern’s A.I.-driven precision oncology pipelineOrphan designation expands LP-284's potential for an ...

Vaxcyte Doses First Participants in Phase 3 Study Evaluating Concomitant Administration of VAX-31 and Seasonal Influenza ...

A vaccine created by University of Georgia researchers to battle multiple life-threatening fungal infections is also ...

Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they ...